Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.

NCT02083380 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

448

Enrollment

OTHER

Sponsor class

Conditions

Uncomplicated Plasmodium Falciparum Malaria

Interventions

DRUG: Artefenomel 800mg: piperaquine 640mg
DRUG: Artefenomel 800mg: piperaquine 960mg
DRUG: Artefenomel 800mg: piperaquine 1440mg

Sponsor

Medicines for Malaria Venture